News|Articles|November 11, 2025
Biomarker-Specific De Novo Assay Creation
Key Takeaways
De novo assay development holds great promise for future drug discovery projects, potentially reducing costs, improving success rates, and ultimately benefiting patients by accelerating the development of safe and effective therapeutics. Learn what you need to know with regard to new biomarker assay development.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
5